Clinical Trials Logo

Binge-Eating Disorder clinical trials

View clinical trials related to Binge-Eating Disorder.

Filter by:

NCT ID: NCT01291173 Completed - Clinical trials for Binge Eating Disorder

Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder

BED
Start date: May 10, 2011
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week

NCT ID: NCT01282736 Completed - Clinical trials for Binge Eating Disorder

Guided Self-Help for Binge Eating Disorder

Start date: June 2010
Phase: N/A
Study type: Interventional

The proposed study will employ a randomized design to evaluate the efficacy of two group-based guided self-help treatments: Integrative Response Therapy (IRT) and Cognitive Behavior Therapy Guided Self-Help, a treatment of known efficacy, in group-format (CBT-GSHg) in the treatment of Binge Eating Disorder (BED), and explore (1) moderators and mediators of treatment, (2) the relative cost-effectiveness of the two treatments, and (3) between group differences on secondary measures (e.g., eating disorder and general psychopathology).

NCT ID: NCT01208272 Completed - Clinical trials for Binge Eating Disorder

Psychological Treatment of Overweight Binge Eaters

Start date: April 1994
Phase: Phase 1/Phase 2
Study type: Interventional

Cognitive-behavioral therapy (CBT) has documented efficacy for the treatment of binge eating disorder (BED). Interpersonal psychotherapy (IPT) has been shown to reduce binge eating but its long-term impact and time course on other BED-related symptoms remain largely unknown. This study compares the effects of group CBT and group IPT across BED-related symptoms among overweight individuals with BED.

NCT ID: NCT01208259 Completed - Clinical trials for Binge Eating Disorder

The Psychological Treatment of Overweight Binge Eaters Minority Supplement

Start date: April 1997
Phase: Phase 1/Phase 2
Study type: Interventional

Cognitive-behavioral therapy (CBT) has documented efficacy for the treatment of binge eating disorder (BED). Interpersonal psychotherapy (IPT) has been shown to reduce binge eating but its long-term impact and time course on other BED-related symptoms remain largely unknown. This study compares the effects of group CBT and group IPT across BED-related symptoms among overweight individuals with BED.

NCT ID: NCT01098435 Completed - Clinical trials for Binge Eating Disorder

ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder

Start date: May 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety of daily doses of RDC-0313 (ALKS 33) compared with placebo in adults with binge-eating disorder (BED). An additional objective is to explore the efficacy of RDC-0313 treatment in comparison with placebo in adults with binge-eating disorder.

NCT ID: NCT01096251 Completed - Obesity Clinical Trials

STRATOB: a Randomized Controlled Clinical Trial of Cognitive Behavioural Therapy and Brief Strategic Therapy With Telecare for Binge-eating Disorder

STRATOB
Start date: January 2008
Phase: N/A
Study type: Interventional

The STRATOB study is a two-arm randomized controlled clinical trial (RCT). The aims of this study are to compare the effectiveness of the BST (Brief Strategic Therapy) with the gold standard CBT (Cognitive Behavior Therapy) in a inpatient and telephone-based outpatient program in a sample of obese people with BED (Binge Eating Disorder) seeking treatment for weight reduction.

NCT ID: NCT01090713 Completed - Clinical trials for Binge Eating Disorder

Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder

NCT ID: NCT01010789 Completed - Overweight Clinical Trials

Armodafinil in Binge Eating Disorder (BED)

Start date: November 2009
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to study the effectiveness, tolerability and safety of armodafinil in outpatients with binge eating disorder.

NCT ID: NCT00965705 Completed - Clinical trials for Binge Eating Disorder

Stepped Care Treatment for Binge-Eating

Start date: June 2009
Phase: N/A
Study type: Interventional

Temple University is looking for women to participate in a study to evaluate the treatment options available to women living with binge eating disorder. Binge-Eating Disorder is a significant public health problem for women. Despite this, there is limited research on how best to treat this disorder at varying levels of severity. The purpose of this NIMH-funded study is to enroll individuals in a brief form of cognitive-behavior therapy. If more intense treatment is needed, individuals will be randomly assigned to more intensive group and individual treatments (Cognitive-Behavior Therapy or Dialectical Behavior Therapy). Both of these treatments are talking therapies that have been adapted for women living with binge-eating disorder and are free of charge.

NCT ID: NCT00904306 Completed - Clinical trials for Binge Eating Disorder

Binge Eating and Chromium Study

BEACh
Start date: July 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to test the feasibility and preliminary efficacy of a 6-month chromium picolinate (CrPic) treatment trial in binge eating disorder (BED).